PIK3CA Mutations trials recruiting in Tennessee

Fewer than 3 recruiting trials found.

All PIK3CA Mutations trials nationally

Cities in Tennessee

Recruiting trials in Tennessee

• A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
  NCT07383506 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Tennessee: Nashville